Promega at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Promega brings 4 presentations to ESGCT 2026 in Hamburg. Its contributions centre on bioluminescent assays for cell and gene therapy testing, covering mechanism-based CAR T potency and antibodies against AAV in serum. Other work profiles metabolites to tune T cell activation during manufacturing and checks how well lipid nanoparticles hold their cargo.
| Organization | ESGCT 2026 Attendance |
|---|---|
Promega Madison, WI | ◇Silver Sponsor |
Supplies bioassays and reagents for cell and gene therapy, including reporter and target-cell killing assays, cytokine immunoassays and AAV and lentivirus characterization. | Poster Wed Oct 28 1:30pm–3:30pm Bioluminescent metabolite profiling as an in‑process tool to tune T‑cell activation for celltherapy manufacturing. Poster Wed Oct 28 1:30pm–3:30pm New Bioluminescence Methods for MOA-BASED CAR-T Potency Testing Poster Thu Oct 29 2:00pm–4:00pm Novel Bioluminescent Assays for Detecting Anti-AAV Neutralizing and Total Antibodies in Serum Samples Poster Thu Oct 29 2:00pm–4:00pm Sequence-specific evaluation of encapsulation efficiency in single and multi-cargo lipid nanoparticles. |
Instantly find 20 buyers from Promega
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction